S.Biomedics Statistics
Total Valuation
S.Biomedics has a market cap or net worth of KRW 273.96 billion. The enterprise value is 280.03 billion.
| Market Cap | 273.96B | 
| Enterprise Value | 280.03B | 
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
S.Biomedics has 11.86 million shares outstanding. The number of shares has increased by 3.70% in one year.
| Current Share Class | 11.86M | 
| Shares Outstanding | 11.86M | 
| Shares Change (YoY) | +3.70% | 
| Shares Change (QoQ) | +0.82% | 
| Owned by Insiders (%) | 22.60% | 
| Owned by Institutions (%) | 0.01% | 
| Float | 8.60M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | 16.02 | 
| PB Ratio | 18.37 | 
| P/TBV Ratio | 38.20 | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | -31.68 | 
| EV / Sales | 16.38 | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | -40.15 | 
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 1.28.
| Current Ratio | 2.17 | 
| Quick Ratio | 1.91 | 
| Debt / Equity | 1.28 | 
| Debt / EBITDA | n/a | 
| Debt / FCF | -2.74 | 
| Interest Coverage | -7.77 | 
Financial Efficiency
Return on equity (ROE) is -65.37% and return on invested capital (ROIC) is -14.52%.
| Return on Equity (ROE) | -65.37% | 
| Return on Assets (ROA) | -10.83% | 
| Return on Invested Capital (ROIC) | -14.52% | 
| Return on Capital Employed (ROCE) | -20.31% | 
| Revenue Per Employee | 316.60M | 
| Profits Per Employee | -163.67M | 
| Employee Count | 54 | 
| Asset Turnover | 0.48 | 
| Inventory Turnover | 3.66 | 
Taxes
In the past 12 months, S.Biomedics has paid 104.25 million in taxes.
| Income Tax | 104.25M | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has decreased by -14.19% in the last 52 weeks. The beta is 1.83, so S.Biomedics's price volatility has been higher than the market average.
| Beta (5Y) | 1.83 | 
| 52-Week Price Change | -14.19% | 
| 50-Day Moving Average | 22,652.60 | 
| 200-Day Moving Average | 22,067.25 | 
| Relative Strength Index (RSI) | 45.21 | 
| Average Volume (20 Days) | 176,617 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
In the last 12 months, S.Biomedics had revenue of KRW 17.10 billion and -8.84 billion in losses. Loss per share was -754.38.
| Revenue | 17.10B | 
| Gross Profit | 7.77B | 
| Operating Income | -6.18B | 
| Pretax Income | -7.40B | 
| Net Income | -8.84B | 
| EBITDA | -4.32B | 
| EBIT | -6.18B | 
| Loss Per Share | -754.38 | 
Balance Sheet
The company has 20.42 billion in cash and 19.13 billion in debt, giving a net cash position of 1.28 billion or 108.34 per share.
| Cash & Cash Equivalents | 20.42B | 
| Total Debt | 19.13B | 
| Net Cash | 1.28B | 
| Net Cash Per Share | 108.34 | 
| Equity (Book Value) | 14.91B | 
| Book Value Per Share | 637.43 | 
| Working Capital | 13.77B | 
Cash Flow
In the last 12 months, operating cash flow was -3.99 billion and capital expenditures -2.98 billion, giving a free cash flow of -6.97 billion.
| Operating Cash Flow | -3.99B | 
| Capital Expenditures | -2.98B | 
| Free Cash Flow | -6.97B | 
| FCF Per Share | -588.03 | 
Margins
Gross margin is 45.44%, with operating and profit margins of -36.12% and -51.70%.
| Gross Margin | 45.44% | 
| Operating Margin | -36.12% | 
| Pretax Margin | -43.29% | 
| Profit Margin | -51.70% | 
| EBITDA Margin | -25.29% | 
| EBIT Margin | -36.12% | 
| FCF Margin | n/a | 
Dividends & Yields
S.Biomedics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -3.70% | 
| Shareholder Yield | -3.70% | 
| Earnings Yield | -3.23% | 
| FCF Yield | -2.55% | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
S.Biomedics has an Altman Z-Score of 4.3 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.3 | 
| Piotroski F-Score | 3 |